Serialisation represents a significant challenge for CDMOs, with multiple factors to consider, from varying market regulations to data storage and exchange.

Failing to overcome these challenges ahead of the looming deadlines in the US and Europe can lead to costly downtime, product shortages and even loss of business in key markets. As a result, CDMOs need to proactively ensure they have a robust solution in place and are well prepared ahead of the regulations coming into force.

Serialisation represents a significant challenge for CDMOs.

In an article published by European Pharmaceutical Manufacturer, our vice president of manufacturing services, Erik Haeffler, examines the serialisation landscape in more detail and talks about the challenges and opportunities that serialisation presents for CDMOs. Read the full article here: The serialisation landscape: Challenges and opportunities for a CDMO

Erik was also one of the keynote speakers at this year’s NEXUS event in Barcelona. An annual event which brings together professionals from across the pharmaceutical supply chain to discuss the future of worldwide drug traceability.